These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1957327)

  • 1. Eosinophilia caused by administration of L-tryptophan to animals with adrenal dysfunction.
    Shishikura T; Tsuchiya T; Sato F; Oguro K; Ebisawa H
    Toxicol Lett; 1991 Nov; 58(3):315-21. PubMed ID: 1957327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cause and pathogenesis of the eosinophilia-myalgia syndrome.
    Varga J; Uitto J; Jimenez SA
    Ann Intern Med; 1992 Jan; 116(2):140-7. PubMed ID: 1727618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of L-tryptophan eosinophilia myalgia syndrome.
    Sternberg EM
    Adv Exp Med Biol; 1996; 398():325-30. PubMed ID: 8906284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low doses of L-tryptophan are lethal in rats with adrenal insufficiency.
    Trulson ME; Ulissey MJ
    Life Sci; 1987 Jul; 41(3):349-53. PubMed ID: 3079519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,1'-Ethylidenebis(tryptophan) (Peak E) induces functional activation of human eosinophils and interleukin 5 production from T lymphocytes: association of eosinophilia-myalgia syndrome with a L-tryptophan contaminant.
    Yamaoka KA; Miyasaka N; Inuo G; Saito I; Kolb JP; Fujita K; Kashiwazaki S
    J Clin Immunol; 1994 Jan; 14(1):50-60. PubMed ID: 8132737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A decomposition product of a contaminant implicated in L-tryptophan eosinophilia myalgia syndrome affects spinal cord neuronal cell death and survival through stereospecific, maturation and partly interleukin-1-dependent mechanisms.
    Brenneman DE; Page SW; Schultzberg M; Thomas FS; Zelazowski P; Burnet P; Avidor R; Sternberg EM
    J Pharmacol Exp Ther; 1993 Aug; 266(2):1029-35. PubMed ID: 8355179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A murine model of the eosinophilia-myalgia syndrome induced by 1,1'-ethylidenebis (L-tryptophan).
    Silver RM; Ludwicka A; Hampton M; Ohba T; Bingel SA; Smith T; Harley RA; Maize J; Heyes MP
    J Clin Invest; 1994 Apr; 93(4):1473-80. PubMed ID: 8163652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophilia-myalgia syndrome in Germany: an epidemiologic review.
    Carr L; Rüther E; Berg PA; Lehnert H
    Mayo Clin Proc; 1994 Jul; 69(7):620-5. PubMed ID: 8015323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-tryptophan and the eosinophilia-myalgia syndrome: a clinical and laboratory study.
    McKeon P; Swanwick G; Manley P
    Acta Psychiatr Scand; 1994 Dec; 90(6):451-4. PubMed ID: 7892779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,1'-Ethylidenebis[tryptophan] induces pathologic alterations in muscle similar to those observed in the eosinophilia-myalgia syndrome.
    Emslie-Smith AM; Mayeno AN; Nakano S; Gleich GJ; Engel AG
    Neurology; 1994 Dec; 44(12):2390-2. PubMed ID: 7991132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of L-tryptophan products on function of human eosinophils: investigation of the causal mechanisms of eosinophilia myalgia syndrome associated with L-tryptophan products.
    Saito H; Miyamoto T
    Int Arch Allergy Immunol; 1996; 111 Suppl 1():37-42. PubMed ID: 8906111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of polyclonal antibodies against 1,1'-ethyliden bis[L-tryptophan] (EBT), a potential contaminant causing eosinophilia-myalgia syndrome (EMS).
    Kurihara N; Yanagisawa H; Jin Z; Wada O
    Toxicol Lett; 1993 Mar; 66(3):231-6. PubMed ID: 8475503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-tryptophan implicated in human eosinophilia-myalgia syndrome causes fasciitis and perimyositis in the Lewis rat.
    Crofford LJ; Rader JI; Dalakas MC; Hill RH; Page SW; Needham LL; Brady LS; Heyes MP; Wilder RL; Gold PW
    J Clin Invest; 1990 Nov; 86(5):1757-63. PubMed ID: 2243145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Eosinophilia-myalgia syndrome].
    Kotake S; Kashiwazaki S
    Nihon Rinsho; 1992 Jul; 50(7):1650-5. PubMed ID: 1404896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of the eosinophilia-myalgia syndrome].
    Ishikawa A; Akahosi T; Okada J; Kondo H; Kasiwazaki S
    Ryumachi; 1992 Aug; 32(4):327-30; discussion 330-2. PubMed ID: 1411794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of synthesized constituents in the L-tryptophan product on the differentiation of eosinophils and the induction of IL-6: a possible cause of eosinophilia-myalgia syndrome.
    Yamaguchi Y; Tsunoda J; Suda T; Miura Y; Shioiri-Nakano K; Kasahara T
    Biochem Biophys Res Commun; 1991 Aug; 178(3):1008-13. PubMed ID: 1872826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-tryptophan and the eosinophilia-myalgia syndrome: current understanding of the etiology and pathogenesis.
    Varga J; Jimenez SA; Uitto J
    J Invest Dermatol; 1993 Jan; 100(1):97S-105S. PubMed ID: 8423409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological and immunological effects of ingesting L-tryptophan and 1,1'-ethylidenebis (L-tryptophan) in Lewis rats.
    Love LA; Rader JI; Crofford LJ; Raybourne RB; Principato MA; Page SW; Trucksess MW; Smith MJ; Dugan EM; Turner ML
    J Clin Invest; 1993 Mar; 91(3):804-11. PubMed ID: 8450062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Eosinophilia-myalgia: new syndrome].
    Szechiński J; Borysewicz K
    Postepy Hig Med Dosw; 1992; 46(3):319-25. PubMed ID: 1369828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal models of the eosinophilia-myalgia syndrome.
    Clauw DJ
    J Rheumatol Suppl; 1996 Oct; 46():93-7; discussion 92, 97-8. PubMed ID: 8895185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.